Palantir's DoD contracts, strong Q1 2025 growth, and competitive edge in AI-driven platforms make it a standout growth ...

Red Violet is a top pick in data analytics with strong financials, recurring revenue, and industry tailwinds. Click here to ...

Kestra Medical Technologies, Ltd. sees sales growth but struggles with losses and slowing revenue. Click for risks tied to ...

Oklo's $1B offering raises red flags including financial setbacks, regulatory hurdles, and shifting strategies amid optimism ...

Arcos Dorados Holdings (ARCO), the world’s largest independent McDonald’s franchisee, has appointed Luis Raganato as its new chief executive officer, effective ...

Within the S&P 500, 32 stocks now have market caps of at least $250 billion. Of those, four have traded at all-time highs ...

The backlog for contract oil driller Valaris remains strong. Read why recent share buybacks signal management’s confidence ...

Explore REGENXBIO's RGX-121 gene therapy for Hunter syndrome, with an FDA decision due Nov 9, 2025. Click here to read my ...

Gold broke out of its descending daily channel on Monday, supported by early-week US Dollar weakness. Click to read.

Rivian's initial promise has faded amid ongoing losses, weak BEV demand, and significant capital burn. Click here to read an ...

AnaptysBio, Inc.'s rosnilimab shows promise in RA & ulcerative colitis, targeting $20B+ markets. Phase 2b results highlight ...

Healthcare Realty Trust is dealing with post-merger challenges and volatility. Read my analysis of HR and why its HOLD rating ...